Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes

Philip E. Chen, Matthew T. Geballe, Elyse Katz, Kevin Erreger, Matthew R. Livesey, Kate K. O'toole, Phuong Le, Changjoon Lee, James P. Snyder, Stephen F. Traynelis, David J A Wyllie

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Heteromeric NMDARs are composed of coagonist glycine-binding NR1 subunits and glutamate-binding NR2 subunits. The majority of functional NMDARs in the mammalian central nervous system (CNS) contain two NR1 subunits and two NR2 subunits of which there are four types (A-D). We show that the potency of a variety of endogenous and synthetic glycine-site coagonists varies between recombinant NMDARs such that the highest potency is seen at NR2D-containing and the lowest at NR2A-containing NMDARs. This heterogeneity is specified by the particular NR2 subunit within the NMDAR complex since the glycine-binding NR1 subunit is common to all NMDARs investigated. To identify the molecular determinants responsible for this heterogeneity, we generated chimeric NR2A/2D subunits where we exchanged the S1 and S2 regions that form the ligand-binding domains and coexpressed these with NR1 subunits in Xenopus laevis oocytes. Glycine concentration-response curves for NMDARs containing NR2A subunits including the NR2D S1 region gave mean glycine EC 50 values similar to NR2A(WT)-containing NMDARs. However, receptors containing NR2A subunits including the NR2D S2 region or both NR2D S1 and S2 regions gave glycine potencies similar to those seen in NR2D(WT)-containing NMDARs. In particular, two residues in the S2 region of the NR2A subunit (Lys719 and Tyr735) when mutated to the corresponding residues found in the NR2D subunit influence glycine potency. We conclude that the variation in glycine potency is caused by interactions between the NR1 and NR2 ligand-binding domains that occur following agonist binding and which may be involved in the initial conformation changes that determine channel gating.

Original languageEnglish
Pages (from-to)227-245
Number of pages19
JournalJournal of Physiology
Volume586
Issue number1
DOIs
Publication statusPublished - 2008 Jan 1
Externally publishedYes

Fingerprint

Xenopus laevis
N-Methyl-D-Aspartate Receptors
Glycine
Oocytes
Ligands
Glutamic Acid
Central Nervous System

ASJC Scopus subject areas

  • Physiology

Cite this

Chen, P. E., Geballe, M. T., Katz, E., Erreger, K., Livesey, M. R., O'toole, K. K., ... Wyllie, D. J. A. (2008). Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. Journal of Physiology, 586(1), 227-245. https://doi.org/10.1113/jphysiol.2007.143172

Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. / Chen, Philip E.; Geballe, Matthew T.; Katz, Elyse; Erreger, Kevin; Livesey, Matthew R.; O'toole, Kate K.; Le, Phuong; Lee, Changjoon; Snyder, James P.; Traynelis, Stephen F.; Wyllie, David J A.

In: Journal of Physiology, Vol. 586, No. 1, 01.01.2008, p. 227-245.

Research output: Contribution to journalArticle

Chen, PE, Geballe, MT, Katz, E, Erreger, K, Livesey, MR, O'toole, KK, Le, P, Lee, C, Snyder, JP, Traynelis, SF & Wyllie, DJA 2008, 'Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes', Journal of Physiology, vol. 586, no. 1, pp. 227-245. https://doi.org/10.1113/jphysiol.2007.143172
Chen, Philip E. ; Geballe, Matthew T. ; Katz, Elyse ; Erreger, Kevin ; Livesey, Matthew R. ; O'toole, Kate K. ; Le, Phuong ; Lee, Changjoon ; Snyder, James P. ; Traynelis, Stephen F. ; Wyllie, David J A. / Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. In: Journal of Physiology. 2008 ; Vol. 586, No. 1. pp. 227-245.
@article{c3b39f57877441daa0f795f42c4df50e,
title = "Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes",
abstract = "Heteromeric NMDARs are composed of coagonist glycine-binding NR1 subunits and glutamate-binding NR2 subunits. The majority of functional NMDARs in the mammalian central nervous system (CNS) contain two NR1 subunits and two NR2 subunits of which there are four types (A-D). We show that the potency of a variety of endogenous and synthetic glycine-site coagonists varies between recombinant NMDARs such that the highest potency is seen at NR2D-containing and the lowest at NR2A-containing NMDARs. This heterogeneity is specified by the particular NR2 subunit within the NMDAR complex since the glycine-binding NR1 subunit is common to all NMDARs investigated. To identify the molecular determinants responsible for this heterogeneity, we generated chimeric NR2A/2D subunits where we exchanged the S1 and S2 regions that form the ligand-binding domains and coexpressed these with NR1 subunits in Xenopus laevis oocytes. Glycine concentration-response curves for NMDARs containing NR2A subunits including the NR2D S1 region gave mean glycine EC 50 values similar to NR2A(WT)-containing NMDARs. However, receptors containing NR2A subunits including the NR2D S2 region or both NR2D S1 and S2 regions gave glycine potencies similar to those seen in NR2D(WT)-containing NMDARs. In particular, two residues in the S2 region of the NR2A subunit (Lys719 and Tyr735) when mutated to the corresponding residues found in the NR2D subunit influence glycine potency. We conclude that the variation in glycine potency is caused by interactions between the NR1 and NR2 ligand-binding domains that occur following agonist binding and which may be involved in the initial conformation changes that determine channel gating.",
author = "Chen, {Philip E.} and Geballe, {Matthew T.} and Elyse Katz and Kevin Erreger and Livesey, {Matthew R.} and O'toole, {Kate K.} and Phuong Le and Changjoon Lee and Snyder, {James P.} and Traynelis, {Stephen F.} and Wyllie, {David J A}",
year = "2008",
month = "1",
day = "1",
doi = "10.1113/jphysiol.2007.143172",
language = "English",
volume = "586",
pages = "227--245",
journal = "Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes

AU - Chen, Philip E.

AU - Geballe, Matthew T.

AU - Katz, Elyse

AU - Erreger, Kevin

AU - Livesey, Matthew R.

AU - O'toole, Kate K.

AU - Le, Phuong

AU - Lee, Changjoon

AU - Snyder, James P.

AU - Traynelis, Stephen F.

AU - Wyllie, David J A

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Heteromeric NMDARs are composed of coagonist glycine-binding NR1 subunits and glutamate-binding NR2 subunits. The majority of functional NMDARs in the mammalian central nervous system (CNS) contain two NR1 subunits and two NR2 subunits of which there are four types (A-D). We show that the potency of a variety of endogenous and synthetic glycine-site coagonists varies between recombinant NMDARs such that the highest potency is seen at NR2D-containing and the lowest at NR2A-containing NMDARs. This heterogeneity is specified by the particular NR2 subunit within the NMDAR complex since the glycine-binding NR1 subunit is common to all NMDARs investigated. To identify the molecular determinants responsible for this heterogeneity, we generated chimeric NR2A/2D subunits where we exchanged the S1 and S2 regions that form the ligand-binding domains and coexpressed these with NR1 subunits in Xenopus laevis oocytes. Glycine concentration-response curves for NMDARs containing NR2A subunits including the NR2D S1 region gave mean glycine EC 50 values similar to NR2A(WT)-containing NMDARs. However, receptors containing NR2A subunits including the NR2D S2 region or both NR2D S1 and S2 regions gave glycine potencies similar to those seen in NR2D(WT)-containing NMDARs. In particular, two residues in the S2 region of the NR2A subunit (Lys719 and Tyr735) when mutated to the corresponding residues found in the NR2D subunit influence glycine potency. We conclude that the variation in glycine potency is caused by interactions between the NR1 and NR2 ligand-binding domains that occur following agonist binding and which may be involved in the initial conformation changes that determine channel gating.

AB - Heteromeric NMDARs are composed of coagonist glycine-binding NR1 subunits and glutamate-binding NR2 subunits. The majority of functional NMDARs in the mammalian central nervous system (CNS) contain two NR1 subunits and two NR2 subunits of which there are four types (A-D). We show that the potency of a variety of endogenous and synthetic glycine-site coagonists varies between recombinant NMDARs such that the highest potency is seen at NR2D-containing and the lowest at NR2A-containing NMDARs. This heterogeneity is specified by the particular NR2 subunit within the NMDAR complex since the glycine-binding NR1 subunit is common to all NMDARs investigated. To identify the molecular determinants responsible for this heterogeneity, we generated chimeric NR2A/2D subunits where we exchanged the S1 and S2 regions that form the ligand-binding domains and coexpressed these with NR1 subunits in Xenopus laevis oocytes. Glycine concentration-response curves for NMDARs containing NR2A subunits including the NR2D S1 region gave mean glycine EC 50 values similar to NR2A(WT)-containing NMDARs. However, receptors containing NR2A subunits including the NR2D S2 region or both NR2D S1 and S2 regions gave glycine potencies similar to those seen in NR2D(WT)-containing NMDARs. In particular, two residues in the S2 region of the NR2A subunit (Lys719 and Tyr735) when mutated to the corresponding residues found in the NR2D subunit influence glycine potency. We conclude that the variation in glycine potency is caused by interactions between the NR1 and NR2 ligand-binding domains that occur following agonist binding and which may be involved in the initial conformation changes that determine channel gating.

UR - http://www.scopus.com/inward/record.url?scp=37849009751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37849009751&partnerID=8YFLogxK

U2 - 10.1113/jphysiol.2007.143172

DO - 10.1113/jphysiol.2007.143172

M3 - Article

C2 - 17962328

AN - SCOPUS:37849009751

VL - 586

SP - 227

EP - 245

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 1

ER -